SEC 13F Intelligence

Isthmus Partners, LLC / CELG

Isthmus Partners, LLC’s Celgene Corp Position

Does Isthmus Partners, LLC own Celgene Corp (CELG)? Not currently — the last reported position was 85.5K shares worth $8M in Q3 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$8M
Q3 2019
Shares
85.5K
% of Portfolio
+2.01%
Quarters Held
3
position exited

Position History CELG

Reported value by quarter
Q4 ’18: $4MQ4 ’18Q2 ’19: $8MQ2 ’19Q3 ’19: $8MQ3 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q3 201985.5K$8M+2.01%
Q2 201986.0K$8M+1.90%
Q4 201856.0K$4M+1.08%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Isthmus Partners, LLC’s full portfolio or all institutional holders of CELG.